30
Participants
Start Date
June 30, 2010
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
CHR-2797
120mg once daily oral for 48 weeks
New York Presbyterian Hospitacl, New York
Duke University Medical Center, Durham
UCLA Division of Hematology/Oncology, Los Angeles
University of Michigan, Ann Arbor
John Theurer Cancer Center, Hackensack
MD Anderson, Houston
Lead Sponsor
Chroma Therapeutics
INDUSTRY